Single Institution Experience With Neoadjuvant Treatment of Borderline Resectable Pancreatic Adenocarcinoma: Achieving R0 Resection With Modern Chemotherapy

被引：0
作者：
Bolton, Nathan
Conway, William C.
Bolton, John S.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
515
引用
收藏
页码：S1018 / S1018
页数：1
相关论文
共 50 条
  • [31] Resectable pancreatic head adenocarcinoma: Is R0 resection an illusion? Genetic evaluation of venous resection margin affirmed unrecognized disease
    Turrini, O.
    Gilabert, M.
    Ewald, J.
    Moutardier, V.
    Delpero, J. -R.
    Iovanna, J. -L.
    [J]. JOURNAL OF VISCERAL SURGERY, 2017, 154 (05) : 329 - 333
  • [32] R0 resection for ductal pancreatic cancer - Japanese experience
    Matsuno, Seiki
    Egawa, Shinichi
    Unno, Michiaki
    [J]. AMERICAN JOURNAL OF SURGERY, 2007, 194 (4A) : S110 - S114
  • [33] Efficacy and toxicity results of neoadjuvant gemcitabine-based combined chemoradiotherapy in patients with borderline resectable pancreatic adenocarcinoma: A single-institution experience
    Diaz Beveridge, R.
    Garcia-Mora, C.
    Moya, A.
    Bruixola, G.
    Aparicio, J.
    Reche, E.
    Segura, A.
    Caballero, J.
    Gimenez, A.
    Bennis, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S591 - S591
  • [34] Management of Borderline Resectable Pancreatic Adenocarcinoma With Neoadjuvant GTX Chemotherapy Followed by Combined Chemoradiation
    Horowitz, D. P.
    Ebiana, V.
    Gidea-Addeo, D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S192 - S193
  • [35] Surgical Resection Following Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer: Redefining the Standards
    Sandini, M.
    Marchegiani, G.
    Maggino, L.
    Viviani, E.
    Montresor, A.
    Binco, A.
    Malleo, G.
    Salvia, R.
    Bassi, C.
    [J]. PANCREAS, 2016, 45 (10) : 1536 - 1536
  • [36] Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection
    Giovanni Marchegiani
    Valentina Todaro
    Enrico Boninsegna
    Riccardo Negrelli
    Binit Sureka
    Debora Bonamini
    Roberto Salvia
    Riccardo Manfredi
    Roberto Pozzi Mucelli
    Claudio Bassi
    [J]. European Radiology, 2018, 28 : 4265 - 4273
  • [37] Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection
    Marchegiani, Giovanni
    Todaro, Valentina
    Boninsegna, Enrico
    Negrelli, Riccardo
    Sureka, Binit
    Bonamini, Debora
    Salvia, Roberto
    Manfredi, Riccardo
    Mucelli, Roberto Pozzi
    Bassi, Claudio
    [J]. EUROPEAN RADIOLOGY, 2018, 28 (10) : 4265 - 4273
  • [38] Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
    Iyengar, Siddharth
    Nevala-Plagemann, Christopher
    Garrido-Laguna, Ignacio
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [39] Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
    Ei, Shigenori
    Takahashi, Shinichiro
    Ogasawara, Toshihito
    Mashiko, Taro
    Masuoka, Yoshihito
    Nakagohri, Toshio
    [J]. GUT AND LIVER, 2023, 17 (05) : 698 - 710
  • [40] An evaluation of adjuvant chemotherapy following neoadjuvant chemotherapy and resection for borderline resectable and locally advanced pancreatic cancer
    Zhang, Chunmeng
    Wu, Ruiqian
    Smith, Lynette M.
    Baine, Michael
    Lin, Chi
    Reames, Bradley N.
    [J]. AMERICAN JOURNAL OF SURGERY, 2022, 224 (01) : 51 - 57
12345